Correction: Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models.

Correction: Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models.

Bibliographic Details
Main Authors:	Kirsi Penttinen, Heikki Swan, Sari Vanninen, Jere Paavola, Annukka M Lahtinen, Kimmo Kontula, Katriina Aalto-Setälä
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4521935?pdf=render

Similar Items

Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models.
by: Kirsi Penttinen, et al.
Published: (2015-01-01)

Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations.
by: Kirsi Kujala, et al.
Published: (2012-01-01)

The Antiarrhythmic Mechanisms of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia
by: Yukun Li, et al.
Published: (2022-03-01)

Automatic Optimization of an in Silico Model of Human iPSC Derived Cardiomyocytes Recapitulating Calcium Handling Abnormalities
by: Michelangelo Paci, et al.
Published: (2018-06-01)

Cardiac Ischemia On-a-Chip: Antiarrhythmic Effect of Levosimendan on Ischemic Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Mahmoud Gaballah, et al.
Published: (2022-03-01)

HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity
by: Kirsi Penttinen, et al.
Published: (2023-04-01)

Catecholaminergic Polymorphic Ventricular Tachycardia
by: Mohamed Abbas, et al.
Published: (2022-10-01)

Machine learning to differentiate diseased cardiomyocytes from healthy control cells
by: Martti Juhola, et al.
Published: (2019-01-01)

Distinct electrophysiological and mechanical beating phenotypes of long QT syndrome type 1-specific cardiomyocytes carrying different mutations
by: Anna L. Kiviaho, et al.
Published: (2015-09-01)

Catecholaminergic polymorphic ventricular tachycardia in 2012
by: Christian van der Werf, et al.
Published: (2011-12-01)

Arrhythmogenic Mechanism of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Nian Liu, MD, et al.
Published: (2006-01-01)

Bidirectional Ventricular Tachycardia: A Hallmark of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Dr. Francisco Femenia, MD, et al.
Published: (2012-03-01)

Coronary artery disease patient-derived iPSC-hepatocytes have distinct miRNA profile that may alter lipid metabolism
by: Anna Alexanova, et al.
Published: (2023-01-01)

Catecholaminergic polymorphic ventricular tachycardia: An exciting new era
by: Shashank P Behere, et al.
Published: (2016-01-01)

Cardiac Transplantation for Refractory Catecholaminergic Polymorphic Ventricular Tachycardia
by: Sumon Roy, MD, et al.
Published: (2020-09-01)

Advances in the Molecular Genetics of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Junxia Song, et al.
Published: (2021-08-01)

Catecholaminergic polymorphic ventricular tachycardia in pregnancy: a case report
by: Amy Schumer, et al.
Published: (2020-12-01)

Taquicardia ventricular polimórfica catecolaminérgica Catecholaminergic polymorphic ventricular tachycardia
by: Marleny Cruz Cardentey
Published: (2012-06-01)

Percutaneous renal sympathetic denervation in catecholaminergic polymorphic ventricular tachycardia
by: Tolga Aksu, MD, et al.
Published: (2017-06-01)

hiPSC-Derived Cardiomyocyte Model of LQT2 Syndrome Derived from Asymptomatic and Symptomatic Mutation Carriers Reproduces Clinical Differences in Aggregates but Not in Single Cells
by: Disheet Shah, et al.
Published: (2020-05-01)

Novel Analysis Software for Detecting and Classifying Ca2+ Transient Abnormalities in Stem Cell-Derived Cardiomyocytes.
by: Kirsi Penttinen, et al.
Published: (2015-01-01)

Electrophysiological Characteristics and Ablation Outcomes in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
by: Lishui Shen, et al.
Published: (2023-12-01)

CASQ2 variants in Chinese children with catecholaminergic polymorphic ventricular tachycardia
by: Qirui Li, et al.
Published: (2019-11-01)

A case of catecholaminergic polymorphic ventricular tachycardia masquerading as an intractable seizure
by: Reza Shabanian, et al.
Published: (2020-01-01)

Scared to death—A novel mutation in catecholaminergic polymorphic ventricular tachycardia
by: Nikhil Jain, MD, et al.
Published: (2020-05-01)

Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies
by: Abhinav Aggarwal, et al.
Published: (2024-03-01)

Clinical and genetic profiles of chinese pediatric patients with catecholaminergic polymorphic ventricular tachycardia
by: Yu Yan, et al.
Published: (2023-12-01)

Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia: A Translational Perspective for the Clinician-Scientist
by: Dania Kallas, et al.
Published: (2021-08-01)

Catecholaminergic polymorphic ventricular tachycardia detected by an implantable loop recorder in a child
by: Yakup Ergül, et al.
Published: (2013-07-01)

Successful pregnancy in a high-risk catecholaminergic polymorphic ventricular tachycardia patient
by: Inmaculada Mejía Jiménez, et al.
Published: (2022-12-01)

The link between abnormalities of calcium handling proteins and catecholaminergic polymorphic ventricular tachycardia
by: Ding-Jyun Lin, et al.
Published: (2021-01-01)

Catecholaminergic polymorphic ventricular tachycardia. An important diagnosis in children with syncope and normal heart
by: Luiz Roberto Leite, et al.
Published: (2001-01-01)

Improvements in Maturity and Stability of 3D iPSC-Derived Hepatocyte-like Cell Cultures
by: Siiri Suominen, et al.
Published: (2023-09-01)

Catecholaminergic Polymorphic Ventricular Tachycardia: Multiple Clinical Presentations of a Genetically Determined Disease
by: Stjepan Jurisic, et al.
Published: (2023-12-01)

Deadly emotional argument: Sudden cardiac death in catecholaminergic polymorphic ventricular tachycardia (CPVT)
by: Michele Violano, et al.
Published: (2022-08-01)

Catecholaminergic polymorphic ventricular tachycardia patients with multiple genetic variants in the PACES CPVT Registry.
by: Thomas M Roston, et al.
Published: (2018-01-01)

Choking-induced cardiac arrest unmasks a diagnosis of catecholaminergic polymorphic ventricular tachycardia
by: Thomas M. Roston, MD, et al.
Published: (2015-11-01)

Efficacy of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia Is Mutation-Independent but Reduced by Calcium Overload
by: Hyun Seok Hwang, et al.
Published: (2019-08-01)

Molecular Changes in the Cardiac RyR2 With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
by: Angela F. Dulhunty
Published: (2022-02-01)

Current clinical application of dantrolene sodium
by: Hong Seuk Yang, et al.
Published: (2023-07-01)